Off Patent Cancer Drug Shows Promise for Herpes Simplex 1
Researchers from the University of Illinois, Chicago report that doxorubicin, a long-established cancer drug, can block the herpes simplex virus type 1 (HSV-1) in laboratory models and in mice. Their…

